40 results
6-K
EX-99.1
EVAX
Evaxion Biotech A/S
5 Feb 24
Securities Purchase Agreement
7:00am
) are in compliance with all applicable federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including … releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment
F-1/A
EVAX
Evaxion Biotech A/S
30 Jan 24
Registration statement (foreign) (amended)
3:16pm
under applicable US, European and other international regulatory requirements
We face significant competition in an environment of rapid … framework, including elements of the control environment, information and communication, control activities and monitoring of control activities
F-1/A
EX-10.1
EVAX
Evaxion Biotech A/S
30 Jan 24
Registration statement (foreign) (amended)
3:16pm
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata … or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment
F-1
EVAX
Evaxion Biotech A/S
12 Jan 24
Registration statement (foreign)
5:17pm
, European and other international regulatory requirements
We face significant competition in an environment of rapid technological and scientific … elements of the control environment, information and communication, control activities and monitoring of control activities. Therefore, we have
6-K
EX-10.2
id8i8rk
21 Dec 23
Current report (foreign)
4:45pm
6-K
EX-10.1
sc6thih
21 Dec 23
Current report (foreign)
4:45pm
424B4
c6q h9tkbw
13 Sep 23
Prospectus supplement with pricing info
4:45pm
POS AM
cuyfu
25 Aug 23
Prospectus update (post-effective amendment)
5:00pm
6-K
EX-1.1
mvfzkbi6b j4yy
4 Oct 22
Current report (foreign)
8:56am
424B5
zuu oqrnwfzu2f
4 Oct 22
Prospectus supplement for primary offering
8:52am
424B4
vxwljqs6yo1iju8s6
30 Aug 22
Prospectus supplement with pricing info
4:52pm
F-1/A
8b5c fo35hxo5ecs9
22 Aug 22
Registration statement (foreign) (amended)
4:40pm
F-1
xqtsb4dozkyzg
7 Jul 22
Registration statement (foreign)
4:45pm
6-K
EX-10.1
qwmzvwpy0wnwfr4im3j
7 Jun 22
Evaxion Biotech Secures Equity Financing of up to $40 Million from Lincoln Park Capital
5:05pm
424B4
lb3p 73zri
5 Nov 21
Prospectus supplement with pricing info
4:47pm
6-K
EX-1.1
gwnqd6bmhcff
5 Nov 21
Evaxion Biotech Announces Pricing of $24.0 Million Follow-on Public Offering
8:30am
F-1/A
p0gc8hw kkd5sio
3 Nov 21
Registration statement (foreign) (amended)
7:50am